Company & Sponsor Intelligence

Haukeland University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials6

Recruiting4

Completed2

Countries1

Therapeutic footprint

adhdother_psychiatryparkinsonssleep_disorders

Indexed studies

NCT05177055Sleep in Psychiatric Care (SIP): Treatment for Comorbid Delayed Sleep-Wake Phase Disorder (DSWPD)
sleep_disorders · NorwayNA

NCT06998654Feasibility of a Digital Intervention for Patients Frequently Admitted to Psychiatric Acute Wards
other_psychiatry · NorwayNA

NCT03816020NAD-supplementation in Drug naïve Parkinson's Disease
parkinsons · NorwayNA

NCT06299189A Therapist Guided Internet-delivered Treatment for Adults With ADHD (Attention Deficit / Hyperactivity Disorder) - an Open Effectiveness Trial in Routine Care
adhd · NorwayNA

NCT05546567NOPARK Open Label Extension Study
parkinsons · NorwayNA

NCT05589766N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease
parkinsons · NorwayPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →